These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

603 related items for PubMed ID: 17159192

  • 1. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
    Le Deley MC, Suzan F, Cutuli B, Delaloge S, Shamsaldin A, Linassier C, Clisant S, de Vathaire F, Fenaux P, Hill C.
    J Clin Oncol; 2007 Jan 20; 25(3):292-300. PubMed ID: 17159192
    [Abstract] [Full Text] [Related]

  • 2. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D, Neugut AI, Jacobson JS, Wang J, Tsai WY, McBride R, Bennett CL, Grann VR.
    J Natl Cancer Inst; 2007 Feb 07; 99(3):196-205. PubMed ID: 17284714
    [Abstract] [Full Text] [Related]

  • 3. Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma.
    Saso R, Kulkarni S, Mitchell P, Treleaven J, Swansbury GJ, Mehta J, Powles R, Ashley S, Kuan A, Powles T.
    Br J Cancer; 2000 Jul 07; 83(1):91-4. PubMed ID: 10883674
    [Abstract] [Full Text] [Related]

  • 4. Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk.
    Patt DA, Duan Z, Fang S, Hortobagyi GN, Giordano SH.
    J Clin Oncol; 2007 Sep 01; 25(25):3871-6. PubMed ID: 17664457
    [Abstract] [Full Text] [Related]

  • 5. Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide.
    Praga C, Bergh J, Bliss J, Bonneterre J, Cesana B, Coombes RC, Fargeot P, Folin A, Fumoleau P, Giuliani R, Kerbrat P, Hery M, Nilsson J, Onida F, Piccart M, Shepherd L, Therasse P, Wils J, Rogers D.
    J Clin Oncol; 2005 Jun 20; 23(18):4179-91. PubMed ID: 15961765
    [Abstract] [Full Text] [Related]

  • 6. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
    Kröger N, Damon L, Zander AR, Wandt H, Derigs G, Ferrante P, Demirer T, Rosti G, Solid Tumor Working Party of the European Group for Blood and Marrow Transplantation, German Adjuvant Breast Cancer Study Group, University of California, San Francisco.
    Bone Marrow Transplant; 2003 Dec 20; 32(12):1153-7. PubMed ID: 14647269
    [Abstract] [Full Text] [Related]

  • 7. Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.
    Tebbi CK, London WB, Friedman D, Villaluna D, De Alarcon PA, Constine LS, Mendenhall NP, Sposto R, Chauvenet A, Schwartz CL.
    J Clin Oncol; 2007 Feb 10; 25(5):493-500. PubMed ID: 17290056
    [Abstract] [Full Text] [Related]

  • 8. Increased risk of acute myeloid leukaemia after treatment for breast cancer.
    Renella R, Verkooijen HM, Fioretta G, Vlastos G, Kurtz J, Sappino AP, Schäfer P, Neyroud-Caspar I, Bouchardy C.
    Breast; 2006 Oct 10; 15(5):614-9. PubMed ID: 16386906
    [Abstract] [Full Text] [Related]

  • 9. Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia.
    Kalaycio M, Rybicki L, Pohlman B, Sobecks R, Andresen S, Kuczkowski E, Bolwell B.
    J Clin Oncol; 2006 Aug 01; 24(22):3604-10. PubMed ID: 16877727
    [Abstract] [Full Text] [Related]

  • 10. Acute myeloid leukemia and myelodysplastic syndrome following breast cancer: increased frequency of other cancers and of cancers in multiple family members.
    Padmanabhan A, Baker JA, Zirpoli G, Sait SN, Ford LA, Moysich KB, Baer MR.
    Leuk Res; 2008 Dec 01; 32(12):1820-3. PubMed ID: 18468682
    [Abstract] [Full Text] [Related]

  • 11. Risk for the development of treatment-related acute myelocytic leukemia and myelodysplastic syndrome among patients with breast cancer: review of the literature and the National Surgical Adjuvant Breast and Bowel Project experience.
    Smith RE.
    Clin Breast Cancer; 2003 Oct 01; 4(4):273-9. PubMed ID: 14651772
    [Abstract] [Full Text] [Related]

  • 12. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements.
    Andersen MK, Johansson B, Larsen SO, Pedersen-Bjergaard J.
    Haematologica; 1998 Jun 01; 83(6):483-8. PubMed ID: 9676019
    [Abstract] [Full Text] [Related]

  • 13. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
    Creutzig U, Zimmermann M, Lehrnbecher T, Graf N, Hermann J, Niemeyer CM, Reiter A, Ritter J, Dworzak M, Stary J, Reinhardt D.
    J Clin Oncol; 2006 Sep 20; 24(27):4499-506. PubMed ID: 16983120
    [Abstract] [Full Text] [Related]

  • 14. Leukemia incidence following primary breast carcinoma treatment.
    Kaplan HG, Malmgren JA, Atwood M.
    Cancer; 2004 Oct 01; 101(7):1529-36. PubMed ID: 15378478
    [Abstract] [Full Text] [Related]

  • 15. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience.
    Smith RE, Bryant J, DeCillis A, Anderson S, National Surgical Adjuvant Breast and Bowel Project Experience.
    J Clin Oncol; 2003 Apr 01; 21(7):1195-204. PubMed ID: 12663705
    [Abstract] [Full Text] [Related]

  • 16. Myelodysplastic syndrome and acute myeloid leukemia following adjuvant chemotherapy with and without granulocyte colony-stimulating factors for breast cancer.
    Calip GS, Malmgren JA, Lee WJ, Schwartz SM, Kaplan HG.
    Breast Cancer Res Treat; 2015 Nov 01; 154(1):133-43. PubMed ID: 26450505
    [Abstract] [Full Text] [Related]

  • 17. Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study.
    Kaplan H, Malmgren J, De Roos AJ.
    Breast Cancer Res Treat; 2013 Feb 01; 137(3):863-7. PubMed ID: 23274844
    [Abstract] [Full Text] [Related]

  • 18. Cardiac toxicity associated with anthracycline-containing chemotherapy in older women with breast cancer.
    Du XL, Xia R, Liu CC, Cormier JN, Xing Y, Hardy D, Chan W, Burau K.
    Cancer; 2009 Nov 15; 115(22):5296-308. PubMed ID: 19672997
    [Abstract] [Full Text] [Related]

  • 19. Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy.
    Shayne M, Crawford J, Dale DC, Culakova E, Lyman GH, ANC Study Group.
    Breast Cancer Res Treat; 2006 Dec 15; 100(3):255-62. PubMed ID: 16705366
    [Abstract] [Full Text] [Related]

  • 20. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
    Haase D, Hanf V, Schulz T.
    Med Klin (Munich); 2004 Sep 15; 99(9):506-17. PubMed ID: 15372180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.